伸展运动治疗性:有效性,风险和辅助疗法
Mostafa Mehraban Jahromi1, Přemysl Vlček2, Marcela Grünerová Lippertová3
1Third Faculty of Medicine, Charles University, Prague. pt.mehraban@gmail.com.
European journal of translational myology
|June 14, 2024
概括
伸展运动对治疗神经疾病性有好处. 将拉伸与其他疗法 (如造) 结合起来,可以获得更好的效果.
科学领域:
- 神经学 神经学
- 物理疗法物理治疗
- 康复医学 康复医学 康复医学
背景情况:
- 是上部运动神经元疾病 (如中风和多发性硬化症) 的常见,但不太了解的症状.
- 目前治疗的管理策略缺乏绝对的有效性,关于最佳的物理治疗干预措施 (如拉伸) 的争论仍在进行中.
- 的发病率仍然未知,突出需要更好的理解和治疗方法.
研究的目的:
- 为了提供一个全面的概述,有效性和风险与拉伸炼与性管理相关.
- 评估辅助疗法的作用,包括大脑刺激和肉毒素注射,以提高拉伸的疗效.
- 综合当前关于伸展和的联合治疗方法的证据.
主要方法:
- 审查前性和案例研究,检查拉伸对性的影响.
- 对辅助疗法的文献分析,用于与的伸展一起使用.
- 评估支持使用拉伸与造等其他干预措施的证据.
主要成果:
- 来自前性和案例研究的证据表明,伸展有助于控制性.
- 辅助疗法可以通过调节皮质刺激性和肌肉强度来提高伸展的有效性.
- 与简单的拉伸相比,造可能是一个更有效的独立治疗性.
结论:
- 伸展运动在治疗性方面发挥了有益的作用.
- 建议将拉伸与其他治疗方式相结合,如造或肉毒素注射,以提高整体治疗的有效性.
- 可能需要进一步的研究,以优化在多式联络的性管理计划内的伸展的使用.
相关概念视频
Skeletal Muscle Relaxants: Therapeutic Uses
480
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
480
Centrally Acting Muscle Relaxants: Therapeutic Uses
666
Centrally acting muscle relaxants reduce muscle tone and tension by interfering with the postsynaptic reflexes in the central nervous system.
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
666
Skeletal Muscle Relaxants: Adverse Effects
354
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
354
Classification of Skeletal Muscle Relaxants
2.4K
Skeletal muscle relaxants are a group of drugs that can reduce muscle stiffness and induce temporary paralysis to relieve pain. These agents can act centrally to reduce muscle tone or spasms in painful conditions such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), or spinal injuries; they are called antispasmodics or spasmolytics.
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
2.4K
Spasmolytic Agents: Chemical Classification
876
Spasmolytic agents are drugs used to alleviate muscle spasms and spasticity. They can be categorized into different chemical groups based on their mechanisms of action. Centrally acting spasmolytics primarily affect the spinal cord, while others directly target skeletal muscle cells.
A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also...
A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also...
876
Peripherally and Centrally Acting Muscle Relaxants: A Comparison
3.3K
Skeletal muscle relaxants can target the central nervous system [CNS] to reduce muscle tension or act directly at the neuromuscular junction to induce temporary paralysis. These two classes of muscle relaxants are called centrally acting muscle relaxants and peripherally acting muscle relaxants. They differ in their action, mechanism, administration route, and clinical uses.
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic...
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic...
3.3K


